Lab2Clinic™ CNS drug delivery service is an innovative concept which leverages Renishaw’s extensive experience in neurological drug delivery to accelerate the drug development timeline, aiding translation from research to clinical trials.
Intraparenchymal drug delivery offers a practical method of bypassing the blood-brain barrier (BBB) and shows great promise in providing the next step change in the treatment of neurodegenerative, neuro oncology and other debilitating neurological conditi
projít na článekDiffuse intrinsic pontine glioma (DIPG) is a rare but deadly brain tumour. No child has ever survived it, most becoming paralysed and dying in just a few months. Now an novel investigational drug delivery system, which delivers therapeutic agents directly
projít na článekGlobal engineering technologies company, Renishaw, is pleased to announce that its award-winning neuroinfuse™ drug delivery device, the only platform currently to allow for repeated, intermitent infusions into the the parenchyma, has continued to safely a
projít na článekRaman microscopy is routinely used for characterization and identification of material, but the need for this molecular imaging and analysis technique has become increasingly important in biology.
projít na článekA step-change in macro-economic factors led CMM specialists, Apex Metrology Ltd (Apex), to conduct a strategic review of its service offering. Customer demands were changing rapidly and becoming less predictable. Part complexities were increasing, deliver
projít na článek